Multiple sclerosis trials in Slovenia

1 of 5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple Sclerosis

  Where

  Ljubljana

  Age

  18 years and over

  People

  1,800 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07827586